Background: Papillary thyroid cancer (PTC) is the most common subtype of thyroid cancer,
and inflammation relates significantly to its initiation and prognosis. Systematic exploration …

Background Recurrence of papillary thyroid cancer is not uncommon, but incorporating
clinicopathologic parameters to predict recurrence is suboptimal. The aim of this study was …

Background Lymph node metastasis (LNM) in papillary thyroid microcarcinoma (PTMC) is
associated with an increased risk of recurrence and poor prognosis. Sex has been regarded …

New molecular signatures are needed to improve the diagnosis of thyroid cancer (TC) and
avoid unnecessary surgeries. In this study, we aimed to develop a robust and individualized …

The morbidity of thyroid cancer has been rising obviously throughout the world during the
past years. Classic treatment procedure is generally curable for low risk differentiated thyroid …

In order to better understand the mechanisms underlying the development of papillary
thyroid carcinoma (PTC), and to identify new potential biomarkers, high-resolution label-free …

Purpose Identification of stage-specific prognostic/predictive biomarkers in papillary thyroid
carcinoma (PTC) could lead to its more efficient clinical management. The main objective of …

Background: Recent studies have confirmed that immune-associated genes perform a
crucial function in recurrence and metastasis of thyroid carcinoma. A reliable immune …

Simple Summary PLA2R1 is a promising biological candidate for exploitation in thyroid
cancer. However, the mechanism of action of PLA2R1 in thyroid cancer has not been fully …

Papillary thyroid carcinoma (PTC) is the most common type of thyroid carcinoma, and its
incidence has been on the increase in recent years. However, the molecular mechanism of …